Intelligent Bio Solutions (INBS) Current Deferred Revenue (2021 - 2024)
Historic Current Deferred Revenue for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $2.3 million.
- Intelligent Bio Solutions' Current Deferred Revenue rose 10936.24% to $2.3 million in Q1 2024 from the same period last year, while for Mar 2024 it was $2.3 million, marking a year-over-year increase of 10936.24%. This contributed to the annual value of $2.3 million for FY2023, which is 1757.48% down from last year.
- According to the latest figures from Q1 2024, Intelligent Bio Solutions' Current Deferred Revenue is $2.3 million, which was up 10936.24% from $2.4 million recorded in Q4 2023.
- Over the past 5 years, Intelligent Bio Solutions' Current Deferred Revenue peaked at $4.7 million during Q2 2021, and registered a low of $60413.0 during Q3 2022.
- In the last 4 years, Intelligent Bio Solutions' Current Deferred Revenue had a median value of $2.3 million in 2024 and averaged $2.3 million.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 9669.67% in 2022, then surged by 360934.9% in 2023.
- Over the past 4 years, Intelligent Bio Solutions' Current Deferred Revenue (Quarter) stood at $1.8 million in 2021, then grew by 17.73% to $2.2 million in 2022, then increased by 12.95% to $2.4 million in 2023, then fell by 5.89% to $2.3 million in 2024.
- Its Current Deferred Revenue was $2.3 million in Q1 2024, compared to $2.4 million in Q4 2023 and $2.2 million in Q3 2023.